1. Introduction {#sec1}
===============

Refeeding syndrome (RFS) represents a life threatening clinical disorder that happens to occur when restarting feeding in patients with malnutrition or after prolonged starvation \[[@B1]\]. It was first reported among people released from concentration camps following the Second World War. Oral feeding of these severe malnourished individuals often ended in diarrhea, heart failure, neurological complications, and death \[[@B2]--[@B4]\].

Although this condition has been extensively described in the medical literature, it is underdiagnosed and commonly missed in everyday practice \[[@B5]\].

The following is the description of a young woman that was admitted to our internal medicine ward with a prolonged history of feeding problems and severe malnutrition. Attempts to improve her condition resulted in severe electrolyte imbalance and neurological problems compatible with RFS.

2. Case Report {#sec2}
==============

A 25-year-old woman was admitted to our ward because of extreme weakness. She complained of anorexia and considerable weight loss during the last year, sometimes accompanied by nausea and vomiting of unknown cause. She had a previous mental disorder suggesting eating disturbances.

On admission she was cachectic. Her weight was 30 kg and the body mass index (BMI) was 12.5 (normal range: 20--25).

During the first days after admission she received oral intake. She ate by herself and according to her own demands. The patient, her family, and the staff were advised regarding the recommended pace of the feeding process, based on the principle "start low, advance slow." Refeeding was done according to a feeding scheme prepared in advance. The patient was carefully observed by the nursing personnel and her family. Food was given by the nursing personnel and the patient ate small quantities by herself. During feeding she was always accompanied by her family or a nurse.

As the patient was free to eat by herself and was eager to be released, she succeeded in circumventing the recommendations around. Two days after admission at night hours, when accompanied by a member of the family, she ingested large quantity of food, relative to her regular daily intake during the previous days, in a way that suggested a "binge eating." This meal included mainly carbohydrates (simple sugars) and fats with a total caloric intake of 670 calories (49% of calories from carbohydrate and 46% of calories from fat). The recommended daily caloric intake in her condition should be 20 kcal/kg/day, which in her case, weighing 30 kg, should be about 600 kcal per day. The meal she ingested that night increased the total amount of calories ingested by the patient that day to the double allowed on 24 hours.

On the day after the binge meal she complained of weakness and loss of appetite that resulted in a decrease in food intake. Her clinical condition deteriorated. She lost some cognitive abilities and showed psychiatric imbalance. She complained of headache and looked weakened and impassive, with great difficulty in understanding and in giving suitable answers to questions asked. On the same period of time there was a worsening on her legs edema. Hypokalemia was detected. Routine blood tests showed liver function tests abnormalities, electrolytes imbalance, and normal protein (total) and albumin values ([Table 1](#tab1){ref-type="table"}). The chest XR was within normal limits and the ECG showed regular and normal rhythm.

On the second and third day after the "binge eating," severe hypophosphatemia, hypomagnesemia, and hypernatremia were noted and corrected accordingly. Clinical findings at that moment included limb edema, psychomotor agitation, headache, weakness, gastrointestinal unrest, trembling, unstable gait, and ophthalmoplegia (frozen gaze), suggesting thiamine deficiency and Wernicke\'s encephalopathy. The patient was started on thiamine (vitamin B1) 100 mg orally and intravenously, based on her signs and symptoms and the laboratory results previously mentioned. Thiamine (vitamin B1) level prior to treatment was low (16 mg/mL), as later reported. Isolated episodes of hallucinations, convulsions, and syncope occurred sporadically during the next days.

Two days after starting thiamine administration her clinical condition gradually improved. There was an increase in appetite and food ingestion and a marked improvement in blood electrolytes (K^+^, Na^+^) and magnesium values. Blood levels of phosphorus returned to normal afterwards ([Table 1](#tab1){ref-type="table"}).

On the course of hospitalization nutritional guidance was given to the patient and her family and they were informed about the risks involved with uncontrolled eating. In an attempt to reach control of the quantity and quality of food intake by the patient, she was advised to drink a formula of "Ensure Plus" (containing 237 cc/355 kcal/13 gm protein/day divided into small portions during the course of the day), in addition to her usual daily intake. The hours and quantities of food ingested and the daily weight were registered by the nursing staff.

A multidisciplinary teamwork, including physicians, dietician, nursing staff, and social worker, was involved in the treatment of the patient. At the same time, her family was recruited for her support, companion, and backing and for updating and reporting on changes of behavior that could counterbalance nutritional recommendations.

Gradually she started gaining weight and after initial improvement she was transferred to the psychiatric ward. A diagnosis of schizophrenia simplex was done and olanzapine (Zyprexa) was started. Her nutritional condition, under further dietician supervision, progressively improved and on the first month after admission, she gained 4.2 kilograms of weight, representing about 12% of her body weight. On the second month of hospitalization (including her psychiatric hospitalization) she gained another 5.8 kg of weight. In total she regained about 10 kg of weight, representing about 25% of her body weight, and almost returned to her regular weight.

3. Discussion {#sec3}
=============

RFS is the metabolic consequence of poorly controlled refeeding in subjects with severe malnutrition. The syndrome usually occurs after initiating guided feeding by the caregiver, especially of carbohydrates, liquids, and salt in a quantity that the cardiovascular and metabolic systems cannot hold \[[@B6]\].

In the present case, food was self-administered by the patient. As mentioned, this is an unexpected outcome and, to our knowledge, has not been reported before.

Manzanares and Hardy accentuated some of the main features of the RFS, including electrolyte imbalance such as hypophosphatemia, hypokalemia, and hypomagnesemia; RFS increases phosphorylation of glucose and salt and water retention leading to edema and heart failure \[[@B7]\].

The syndrome starts with the administration of glucose. The resultant hyperglycemia stimulates insulin secretion and triggers the intracellular process for energy production which requires phosphate. Phosphate is necessary for the generation of adenosine triphosphate from adenosine diphosphate and adenosine monophosphate and other crucial phosphorylation reactions \[[@B5]\]. There is activation of the Na^+^-K^+^ ATPase transporter resulting in a shift of potassium and phosphate from the extracellular to the intracellular compartment with a consequent drop in serum electrolyte levels resulting in hypophosphatemia, hypokalemia, hypomagnesemia, and the following metabolic acidosis, ketoacidosis, and hyperosmolar states \[[@B7], [@B8]\].

3.1. Hypophosphatemia {#sec3.1}
---------------------

Hypophosphatemia has been described in about 100% of the cases of RFS \[[@B6], [@B9]--[@B11]\]. Hypophosphatemia is almost universally present in cases of RFS and has been used as a surrogate or, perhaps, as the main marker for this syndrome \[[@B6]\]. Intracellular and extracellular hypophosphatemia are present in RFS. As previously mentioned, phosphorus is essential for ATP formation and energy creation, especially from carbohydrate metabolism. Phosphorus deficiency could result in myriad of complications, including hemolysis, rhabdomyolysis, neurological changes, edema, cardiac decompensation, congestive heart failure (CHF) hypotension, arrhythmias pulmonary failure, and death \[[@B5], [@B6], [@B8]\].

3.2. Underdiagnosis {#sec3.2}
-------------------

RFS is well described in the medical literature. Nevertheless, in the usual clinical practice, this condition is overlooked and underdiagnosed.

In the recent review previously cited \[[@B1]\], the authors described a large spectrum of disorders either asymptomatic or, on the contrary, presenting with severe malnutrition, that can result in RFS. The cutoff point for the diagnosis of this syndrome is arbitrary and the diagnosis is based on symptoms and signs. Therefore it is very important to look and detect serum biochemical changes for the correct diagnosis and prevention of the syndrome \[[@B1], [@B11]\]. There are great variations in the essential features of this condition, from asymptomatic cases to those presenting with severe malnutrition, which are at risk of overt and even life threatening symptoms.

The typical presentation of this syndrome is therefore not clear cut. As pointed by Stanga et al., the full-blown syndrome should be defined by the presence of symptoms, but significant biochemical changes should be detected early in order to prevent the clinical features developing. They suggest adapting the terms "symptomatic RFS" and "potential or biochemical RFS" for the various presentations of this syndrome \[[@B1]\].

In 2006 a guideline was published by the National Institute for Health and Clinical Excellence (NICE) in England and Wales that used best available evidence for managing nutrition disorders, including the present condition \[[@B12]\].

Despite publication of these guidelines, awareness of this condition is still lacking and RFS still occurs. Following publication of the NICE recommendations, De Silva et al. surveyed medical personnel and found that only 44% of the physicians were aware of these guidelines and followed up them, in contrast to 70% of the dieticians \[[@B13]\]. Thirty-nine percent of the participants considered that the recommendations have to be followed up as guidance to treatment. Thirty-six percent found the recommendations too strict, whereas other participants reported that they never met a condition such as RFS \[[@B13]\]. The diversified point of view makes necessary further gathering of clinical data in order to set clear guidelines for treatment.

In the paper previously mentioned \[[@B9]\], 48% of the cases of RFS had severe malnutrition, 34% were admitted to an intensive care unit, 25% were oncologic patients, and 9.5% had gastrointestinal fistula.

Because of the nonspecific presentation and rareness, the diagnosis of this disorder is difficult even by those familiar with these conditions. Although not all the subjects at risk will experience RFS, prediction for the specific patient that will contract this disorder is difficult \[[@B9]\]. There is great importance in identifying the groups at risk and the first symptoms and signs of this condition \[[@B11]\]. Not only are patients with extreme malnutrition, including anorexia nervosa, at high risk, but also other groups of subjects experiencing limited supply of food, psychiatric disorders, old age, or increased metabolic demands.

RFS presents usually after oral or parenteral artificial feeding \[[@B1], [@B11], [@B14]\]. RFS after self-administered feeding, as in the present case, is rare.

3.3. Thiamine {#sec3.3}
-------------

As pointed by Manzanares and Hardy, it is likely that thiamine may be one of the contributing factors leading to sudden death during RFS \[[@B7]\].

Thiamine deficiency in acute RFS can cause CHF (wet beriberi) or Wernicke\'s encephalopathy (WE) (dry beriberi). WE is an acute, neuropsychiatric syndrome characterized by acute confusional state, ataxia, hypothermia, and even coma \[[@B11]\].

In one of the articles previously mentioned \[[@B6]\], recollection of RFS cases was done during the years 2000--2011. The authors described 27 cases in whom the syndrome developed on the first 5 days after feeding. A routine vitamin B1 measurement was not performed. Only in one case the level of thiamine was determined and found to be very low, confirming the diagnosis of RFS \[[@B6]\].

In the case we presented, thiamine level was low, and other features typical of WE and RFS were also present.

Thiamine requirement in healthy individuals is 0.5 mg/1000 kcal. The vitamin reservoir could be depleted in 2-3 weeks if new supply is lacking. There are several populations with an increased risk for developing a deficit in vitamin B1. Conditions causing undernutrition are frequently related to thiamine deficiency: malabsorption secondary to surgery or gastrointestinal disease, increase in metabolic demands, and greater renal or gastrointestinal loss of nutrients, including magnesium. The most frequent cause of thiamine deficiency is alcoholism and, as frequently practiced, therapy of an alcoholic bout includes administration of vitamin B1.

Symptoms of deficiency are not specific and include frequent headache, weakness, confusion, opthalmoplegia, ataxia, abdominal discomfort, and cardiovascular manifestations as congestive heart failure \[[@B14], [@B15]\]. These patients may go unrecognized and vitamin treatment is not implemented.

The most significant indication of thiamine deficiency is WE.

A deficit of this vitamin manifests usually after intravenous glucose administration together with increased oral carbohydrate consumption. This results in a metabolic shift from fats to carbohydrate use for energy production, a process requiring increased amounts of thiamine and leading to acute thiamine deficiency.

Conditions related to an increased risk for WE are those causing vitamin B1 deficiency, including alcohol abuse, surgical procedures of the gastrointestinal tract, recurrent vomiting or chronic diarrhea, cancer and chemotherapeutic treatments, and systemic diseases \[[@B16]\] ([Table 2](#tab2){ref-type="table"}).

Therefore, it is mandatory that thiamine be given before or concomitantly with intravenous administration of glucose when risk for WE is suspected. In the present case a dose of 100 mg of thiamine was given.

Although much higher doses are currently recommended by some organizations such as the European Federation of Neurological Societies (EFNS) and the Royal College of Physicians \[[@B17], [@B18]\] (200 mg intravenously 3 times daily and 500 mg three times daily, resp.), these recommendations have not been accepted universally.

In addition, at the time the patient was given 100 mg of thiamine, his weight and BMI were very low (30 and 12, resp.) and we were not certain of a definitive diagnosis of WE. Therefore we chose the lowest dose recommended in the literature. Furthermore, a rapid improvement and the disappearance of symptoms of WE on the following days were noted, explaining why we did not increase the dose of thiamine.

A late Cochrane report commented that the 200 mg dose was superior to the mean result of all the other dosages, but concluded that there is insufficient evidence from randomized controlled clinical trials to guide clinicians in the dose, frequency, route, or duration of thiamine treatment for prophylaxis against, or treatment, of Wernicke-Korsakoff Syndrome (WKS) due to alcohol abuse \[[@B19]\]. Similarly, the EFNS guidelines, previously mentioned, reported that there is no consensus on the optimal dose of thiamine, its preparation form, duration of treatment, or the number of daily doses and that, according to many case reports, treatment with either 100 or 200 mg thiamine given intravenously has cured the disease in the nonalcoholic. They also added that since studies of sufficient quality to warrant a formal recommendation are lacking, there is no evidence to support conclusions as to dosage, route of administration, and treatment time of thiamine \[[@B17]\].

As high levels of vitamin B1 are not toxic, it is recommended that the vitamin be taken uninterruptedly during several months.

In the present case we identified thiamine deficiency during RFS development as a consequence of the "binge eating" that included, as mentioned, large quantities of simple carbohydrates and fats. Worsening of symptoms in our patient occurred 24 hours after the feeding bout and progressed during the following days. Laboratory findings at that time included hypophosphatemia, hypercalcemia, hypokalemia, hypernatremia, and hypoglycemia. As the clinical presentation included features typical of WE, we decided to administer thiamine, both intravenously and orally.

Current guidelines recommend the use of magnetic resonance imaging (MRI) for the diagnosis of WE \[[@B17]\]. In the present case, an MRI was not performed. On the other hand, the patient in this report presented with most of the classical clinical signs in use for the diagnosis of WE. Caine et al. studied clinical features of 28 autopsy-proven alcoholic patients with WE that were well evaluated during life. They found that the sensitivity of the classic triad (eye signs, cerebellar signs, and confusion) for the diagnosis of WE was 23% but rose to 85% if the patients had at least two of the four following features: dietary deficiencies, eye signs, cerebellar signs, and either mild memory impairment or an altered mental state \[[@B20]\].

Our patient had all four clinical features for the diagnosis of WE previously presented. In addition, electrolyte imbalance was present and the patient responded rapidly to the treatment given. Although MRI can confirm the diagnosis, we believe that a reliable diagnosis can be done based on strong clinical features such as in the present patient.

Thiamine was administered and after a few days there was improvement in laboratory parameters and a partial recovery in cognition. Further improvement in physical perception and cognition occurred some days later.

4. Conclusions {#sec4}
==============

Keep in mind the following distinctive features of RFS.High risk groups such as extreme malnutrition.Low levels of phosphorus, magnesium, potassium, and calcium.Low levels of vitamin B1.Hyperglycemia/hypoglycemia.Danger for RFS being higher in the five first days of refeeding.Keeping with the principle "start low, advance slow," when refeeding.

The reported case emphasizes the importance of identifying patients at risk to develop RFS. When acute weight loss is more than 15% of the usual weight, the risk for RFS increases and feeding has to be completed under medical supervision, even if the patient is overweight. Special attention should be given to the electrolyte disturbances, such as hypokalemia, hypophosphatemia, hypomagnesaemia, and their early identification. Thiamine levels should be measured. International guidelines suggest a daily measurement of electrolytes and administration of thiamine before refeeding.

Alertness and collaboration of a multidisciplinary professional team can prevent this disorder from happening in the population at risk. Steps for prevention of this syndrome have to be taken, such as the routine determination of serum electrolytes and phosphorus, and feeding has to be done at a slow controlled pace with special attention to details of micronutrients, such as vitamin B1, that can prevent worsening of the patient condition, forward recovery, and shorten the length of hospitalization. Vitamin B1 should be given intravenously concomitantly with IV glucose.

The question that emerges from this paper is if every patient admitted with extreme weight loss, cachexia, or drastic weight reduction should receive thiamine intravenously on the first three days of hospitalization or when starting nutrition. Should thiamine be given prior to the occurrence of the RFS, as part of a protocol in patients with increased risk for this syndrome?

This question is of crucial importance and hopefully, an answer will be given in the near future.
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###### 

Laboratory results during hospitalization.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Laboratory test        Normal range       Previous admission   Day of admission   Day after the eating bout   Day 2   Day 3   Day 8   Day 29\
                                                                                                                                        Transfer to department of psychiatry
  ---------------------- ------------------ -------------------- ------------------ --------------------------- ------- ------- ------- --------------------------------------
  Glucose                70--100 mg/dL      105                  147                                            85      69              74

  Urea                   17--43 mg/dL       8                    118                26                          10      13              9

  Creatinine             0.51--0.95 mg/dL   0.57                 1.02               0.45                        0.37    0.37            0.32

  Calcium                8.5--10.5 mg/dL    8.92                                                                7.75    8.45             

  Phosphorus             2.5--5 mg/dL       3.40                                                                0.99    1.16            4

  TP^\*^                 6.6--8.3 g/dL      7.6                  7.51               5.61                        5.84    6.44            6.63

  Albumin                3.5--5.2 g/dL      4.33                 4.69               3.48                        3.56    3.96            3.66

  Mg^\*^                 1.6--2.6 mg/dL                                                                         1.58    1.82             

  Na^\*^                 135--145 mmol/L    134                  134                139                         141     139             143

  Potassium              3.5--5.1 mmol/L    3.62                 3.15               2.57                        3.48    4.21            3.76

  Lactate                4.5--19.8 mg/dL                                                                                        21.9     

  Vitamin B1             28--85 mg/mL                                                                                           16       

  Alkaline phosphatase   30--120 u/L        41                   364                182                         162     167             87

  GOT^\*^ (AST)          0--31 u/L          36                   1140               242                         247     263             23

  GPT^\*^ (ALT)          0--34 u/L          23                   518                310                         319     377             21
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^\*^TP: total protein; Mg: magnesium; Na: natrium, sodium; GOT (AST): glutamic oxaloacetic transaminase (aspartate transaminase); GPT (ALT): glutamic-pyruvic transaminase (alanine transaminase).

###### 

Conditions associated with thiamine deficiency.

  ----------------------------------------- --------------------
  Alcoholism                                Anorexia nervosa
  Bariatric surgery                         Chronic vomiting
  Drugs: metformin, omeprazole, diuretics   Diabetes mellitus
  Folic acid deficiency                     Thiaminase
  Chronic diarrhea                          Malignancy
  Hyperemesis gravidarum                    HIV infection
  Diet deficient in thiamine                Malabsorption
  Ataxia type II                            Refeeding syndrome
  Megaloblastic anemia                      Hyperthyroidism
  Chemotherapeutic treatments               Systemic diseases
  ----------------------------------------- --------------------
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